NCT02998255

Brief Summary

Adequate quality of bowel preparation(BP) is important for colonoscopy. Several guidelines recommend that split-dose of 4L PEG should be used as a standard regime for BP. However, the high-volume PEG still results in lower compliance to the regime and increased cost. Some high risk factors for inadequate BP have been identified, including old age, constipation, diabetes, the use of narcotics and prior history of inadequate BP. For average-risk patients without the high risk factors, the procedure of BP could be easier. In the previous study, with the use of single dose of 2L PEG, more than 90% of average-risk patients achieved adequate BP. Here investigators hypothesized that compared with the standard split dose of 4L PEG, single dose of 2L PEG may be not inferior in BP quality while may be accompanied with better tolerability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
940

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2016

Completed
1 day until next milestone

Study Start

First participant enrolled

December 1, 2016

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 20, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

September 13, 2017

Status Verified

July 1, 2017

Enrollment Period

8 months

First QC Date

November 30, 2016

Last Update Submit

September 12, 2017

Conditions

Keywords

PEGBowel preparationColonoscopy

Outcome Measures

Primary Outcomes (1)

  • Rate of adequate bowel preparation(defined as a total BostonBowel Preparation Score ≥6 with each segmental BBPS≥2)

    The adequacy of bowel preparation is defined as Boston Bowel Preparation Scale (BBPS), a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side. They were summed to give the total BBPS score, which ranged from 0 to 9.The withdrawal procedure was recorded by vedios. The BBPS and segmental scores in each segment were judged by one endoscopist who was familiar with the criteria of BBPS and blinded to group allocation.

    1 year

Secondary Outcomes (6)

  • Polyp detection rate

    1 year

  • Rate of adverse events

    1 year

  • Cecal intubation rate

    1 year

  • Cecal intubation time

    1 year

  • Withdrawal time

    1 year

  • +1 more secondary outcomes

Study Arms (2)

Single dose of 2L PEG

EXPERIMENTAL

2 L of PEG solution was used on the day of colonoscopy.

Drug: Single dose of 2L PEG

Split-dose of 4L PEG

ACTIVE COMPARATOR

Split-dose of 4l PEG was used before and on the day of colonoscopy

Drug: Split dose of 4L PEG

Interventions

Patients at average risk for inadequate BP were given instructions for bowel preparation through phone call a day before scheduled colonoscopy. Patients began to drink 2 L of PEG 4-6 hours before colonoscopy at a rate of 250 mL every 15 minutes.

Single dose of 2L PEG

All patients at average risk for inadequate BP were given instructions for bowel preparation through phone call a day before scheduled colonoscopy. the participants began to drink the first 2 L of PEG at 7:00-9:00 PM on the day before colonoscopy at a rate of 250 mL every 15 minutes. On the day of the procedure, patients took the remaining 2 L 4-6 hours before colonoscopy.

Split-dose of 4L PEG

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing colonoscopy;
  • Patients with average risks for inadequate BP (Patients were identified average-risk if they did not meet any factor of the following risk factors):
  • Constipation
  • Diabetes
  • Parkinson's disease
  • History of stroke or spine cord injure
  • Prior history of inadequate bowel preparation
  • BMI\>25
  • Use of tricyclic antidepressant or narcotics

You may not qualify if:

  • History of colorectal resection;
  • Suspected colonic stricture or perforation;
  • Incomplete or complete bowel obstruction;
  • Use of prokinetic agents or purgatives within 7 days;
  • Toxic colitis or megacolon;
  • Pregnancy or lactation;
  • Unable to give informed consent;
  • Haemodynamically unstable.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Department of gastroenterology, Qinghai Provincial People's Hospital

Xining, Qinghai, 810000, China

Location

Department of gastroenterology, Shaanxi Second People's Hospital

Xi'an, Shaanxi, 710032, China

Location

Endoscopic center, Xijing Hospital of Digestive Diseases

Xi’an, Shanxi, 710032, China

Location

MeSH Terms

Conditions

Health Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associated professor

Study Record Dates

First Submitted

November 30, 2016

First Posted

December 20, 2016

Study Start

December 1, 2016

Primary Completion

August 1, 2017

Study Completion

August 1, 2017

Last Updated

September 13, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share

Locations